Location: Hollywood
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Hollywood
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav Phase 3 · Sylvester Comprehensive Cancer Center - Hollywood · Pfizer · NCT05020236 Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS NA · The Medici Medical Research, LLC · Philip Morris Products S.A. · NCT07108166 The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias Phase 1/Phase 2 · Lin BioScience, Inc · NCT05756322 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults Phase N/A · Galderma Investigational Site 7134 · Galderma R&D · NCT06988605 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3) Phase 3 · Behavioral Clinical Research · Bristol-Myers Squibb · NCT06929273 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed Phase 3 · Memorial Regional Hospital/Joe DiMaggio Children's Hospital · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C Phase 3 · Memorial Regional Hospital/Joe DiMaggio Children's Hospital · NRG Oncology · NCT05624996 A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa Phase 4 · Skin Care Research · Eli Lilly and Company · NCT06857942 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop Phase 3 · Memorial Healthcare System - Memorial Regional Hospital · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au Phase 3 · Local Institution - 0168 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma Phase 2 · Memorial Regional Hospital/Joe DiMaggio Children's Hospital · Children's Oncology Group · NCT06368817 To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension Phase 2 · Royal Research Corp · E-Star BioTech, LLC · NCT06343298 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma Phase 2/Phase 3 · Memorial Regional Hospital/Joe DiMaggio Children's Hospital · National Cancer Institute (NCI) · NCT05691478 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN) Phase 3 · Local Institution - 0119 · Bristol-Myers Squibb · NCT07288567 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Zenith Clinical Research · Amgen · NCT07037433 Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency NA · InnoVein · NCT04253301 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr Phase 1 · UM Sylvester Comprehensive Cancer Center at Hollywood · National Cancer Institute (NCI) · NCT06860594 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement Phase 1/Phase 2 · Memorial Healthcare System · Turning Point Therapeutics, Inc. · NCT03093116 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child Phase 3 · Joe Dimaggio Children's Hospital - Cardiology · Bayer · NCT07192952 A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC Phase 1/Phase 2 · Radiopharm Theranostics, Ltd · NCT07259213 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT Phase 2 · Memorial Regional Hospital/Joe DiMaggio Children's Hospital · Children's Oncology Group · NCT04322318 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ Phase 3 · Pfizer · NCT07144280 DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac Phase 2 · BRCR Medical Center Inc. · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617 Collection of Samples USOPTIVAL Study Phase N/A · Center for Gastrointestinal Disorders · Universal Diagnostics · NCT04792684 First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-S EARLY_Phase 1 · Integrated Haematology and Oncology Network · NCT07608848 A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma Phase 2 · Memorial Healthcare System · Janssen Research & Development, LLC · NCT04634552 A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to Phase 3 · Local Institution - 0022 · Bristol-Myers Squibb · NCT04877288 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Phase 2/Phase 3 · Memorial Regional Hospital/Joe DiMaggio Children's Hospital · NRG Oncology · NCT05174169 Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic D Phase 2 · Site Number - 1018 · Immunovant Sciences GmbH · NCT06979531 Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone Phase 1 · Atea Study Site · Atea Pharmaceuticals, Inc. · NCT07314346
Look up another city
Look up another condition